274 Brighton Beach Drugs Inc
Community/Retail Pharmacy
274 Brighton Beach Ave, Brooklyn
New York, 11235-7411
718-648-0002 718-648-0700
274 Brighton Beach Drugs Inc is a Community/Retail Pharmacy in Brooklyn, New York. It is located at 274 Brighton Beach Ave, Brooklyn and it's customer support contact number is 718-648-0002. The authorized person of 274 Brighton Beach Drugs Inc is Naiyla Rafiq who is President of the pharmacy and his contact number is 718-648-0002. Active license number of 274 Brighton Beach Drugs Inc is 035024 for Community/Retail Pharmacy in New York. 274 Brighton Beach Drugs Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
274 Brighton Beach Drugs Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
274 Brighton Beach Drugs Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | 274 Brighton Beach Drugs Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 274 Brighton Beach Ave, Brooklyn,
New York, 11235-7411 |
| Phone: | 718-648-0002 |
| Fax: | 718-648-0700 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Naiyla Rafiq |
| Position: | President |
| Contact Number: | 718-648-0002 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1568912061 |
| NPI Enumeration Date: | 07 Oct, 2016 |
| NPI Last Update On: | 28 Feb, 2017 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for 274 Brighton Beach Drugs Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 035024 | New York | Primary | |
Medicare Enrollment:
274 Brighton Beach Drugs Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 3476822669 | O20170630002164 | 274 Brighton Beach Drugs Inc | DME SUPPLIER - PHARMACY |
Products Available:
274 Brighton Beach Drugs Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | • Canes & Crutches |
| • Heat & Cold Applications | • Nebulizer Equipment & Supplies |
| • Walkers | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 274 Brighton Beach Ave,
Brooklyn, New York |
| Zip: | 11235-7411 |
| Phone Number: | 718-648-0002 |
| Fax Number: | 718-648-0700 |
Patients can reach 274 Brighton Beach Drugs Inc at
274 Brighton Beach Ave, Brooklyn, New York or can
call on customer care at 718-648-0002.
Comments/ Reviews:
Read all the reviews posted for 274 Brighton Beach Drugs Inc below. You may also share your own experience with 274 Brighton Beach Drugs Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.